The Challenge Of Evaluating Annual Mammography Screening For Young Women With A Family History Of Breast Cancer

Rhian Gabe,Stephen W. Duffy,James Mackay,Elaine Anderson,Stephen Duffy, Tan Ellis,Gareth Evans,Hilary Fielder,Jonathon Gray,Gerald Gui, James Mackay,Douglas Macmillan,Sue Moss, Richard Sainsbury,Mark Sibbering, Sue Thomas,Ruth Warren,Eila Watson,Caroline Boggis,John Burn, Paul Dillon, Bob Haward,Anthony Howell,Robert Mansel, Hazel Marshall Cork, John Robertson, Julietta Patnick, Paul Pharoah, Anne Robinson,Stephen Sutton, Amir Al-Dabbagh, Elaine Anderson,Riccardo Audisio, Roger Brookstein, David Brown, Robert Carpenter, Donna Christensen, St John Collier, Julie Cooke, Timothy G. Cooke, Richard Cummins, Diana Dalgliesh,Fiona Douglas, Steve Ebbs, Sian Evans, Cathy Farnon, J. Ferguson, Nick Gallegos, George W. David,Fiona Gilbert, Gerald Gui, D. Hartsell,Shirley Hodgson,Tony Howell, Catheryn Hubbard, Sabah Jmor, Alison Lannigan, Claudio Harding Mackean, Douglas Macmillan, Lee Martin, Duncan Matheson, Mary Milne, Dierdre Pallister,Joan Paterson, Ciduru Ravisekar, Nicola Roche, Linda Rockall, Colin Rogers, Neil Rothnie, Zahida Saad, Richard Sainsbury, Mike Shere, Mark Sibbering, D. Smith, S. Stallard, Kerstin Stepp-Schuh, R. Stewart, William Teh,Alastair Thompson, W. O. Thompson,Philip Turton, Luna Vishwanath, Alison Waghorn,Matthew Wallis, Cilla Wester, Martin Wise, Charles Zammit

Journal of Medical Screening(2006)

引用 35|浏览3
暂无评分
摘要
It has been recommended that women aged 40-49 years with a significant family history of breast cancer should be offered annual mammography screening (http://www.nice.org.uk). An observational study known as FH01 (http: //www. screening services.org/btw/fh01/index.asp) is evaluating this policy in a cohort of 6000 women at moderately increased risk of breast cancer due to family history. The main aims are to assess the likely impact on breast cancer mortality and cost-effectiveness. Measuring these outcomes is challenging in an environment where a randomized trial is not feasible and there is no natural comparison group. In this paper, we present some approaches to estimating effectiveness and the planned analyses. These involve comparison of disease stage and likely consequent breast cancer mortality in the cohort offered screening with that estimated in the absence of screening. The estimation uses observed outcomes in external populations and estimated outcomes for the hypothetical situation where screening had not taken place.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要